Zimmer Biomet Holdings Cash on Hand 2010-2024 | ZBH
Zimmer Biomet Holdings cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Zimmer Biomet Holdings cash on hand for the quarter ending September 30, 2024 was $0.569B, a 94.8% increase year-over-year.
- Zimmer Biomet Holdings cash on hand for 2023 was $0.416B, a 10.67% increase from 2022.
- Zimmer Biomet Holdings cash on hand for 2022 was $0.376B, a 0.63% decline from 2021.
- Zimmer Biomet Holdings cash on hand for 2021 was $0.378B, a 52.86% decline from 2020.
| Zimmer Biomet Holdings Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $416 |
| 2022 | $376 |
| 2021 | $378 |
| 2020 | $802 |
| 2019 | $618 |
| 2018 | $543 |
| 2017 | $524 |
| 2016 | $634 |
| 2015 | $1,624 |
| 2014 | $1,696 |
| 2013 | $1,808 |
| 2012 | $1,556 |
| 2011 | $1,224 |
| 2010 | $934 |
| 2009 | $758 |
| Zimmer Biomet Holdings Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-09-30 | $569 |
| 2024-06-30 | $420 |
| 2024-03-31 | $393 |
| 2023-12-31 | $416 |
| 2023-09-30 | $292 |
| 2023-06-30 | $320 |
| 2023-03-31 | $330 |
| 2022-12-31 | $376 |
| 2022-09-30 | $545 |
| 2022-06-30 | $386 |
| 2022-03-31 | $436 |
| 2021-12-31 | $378 |
| 2021-09-30 | $920 |
| 2021-06-30 | $1,042 |
| 2021-03-31 | $724 |
| 2020-12-31 | $802 |
| 2020-09-30 | $967 |
| 2020-06-30 | $713 |
| 2020-03-31 | $2,434 |
| 2019-12-31 | $618 |
| 2019-09-30 | $513 |
| 2019-06-30 | $403 |
| 2019-03-31 | $587 |
| 2018-12-31 | $543 |
| 2018-09-30 | $525 |
| 2018-06-30 | $481 |
| 2018-03-31 | $1,765 |
| 2017-12-31 | $524 |
| 2017-09-30 | $481 |
| 2017-06-30 | $450 |
| 2017-03-31 | $1,040 |
| 2016-12-31 | $634 |
| 2016-09-30 | $489 |
| 2016-06-30 | $976 |
| 2016-03-31 | $1,010 |
| 2015-12-31 | $1,624 |
| 2015-09-30 | $1,810 |
| 2015-06-30 | $1,884 |
| 2015-03-31 | $9,282 |
| 2014-12-31 | $1,696 |
| 2014-09-30 | $1,747 |
| 2014-06-30 | $1,698 |
| 2014-03-31 | $1,588 |
| 2013-12-31 | $1,808 |
| 2013-09-30 | $1,506 |
| 2013-06-30 | $1,236 |
| 2013-03-31 | $1,201 |
| 2012-12-31 | $1,556 |
| 2012-09-30 | $1,489 |
| 2012-06-30 | $1,336 |
| 2012-03-31 | $1,229 |
| 2011-12-31 | $1,224 |
| 2011-09-30 | $978 |
| 2011-06-30 | $946 |
| 2011-03-31 | $866 |
| 2010-12-31 | $934 |
| 2010-09-30 | $982 |
| 2010-06-30 | $987 |
| 2010-03-31 | $871 |
| 2009-12-31 | $758 |
| 2009-09-30 | $443 |
| 2009-06-30 | $280 |
| 2009-03-31 | $216 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $21.325B | $7.394B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.127B | 25.27 |
| Stryker (SYK) | United States | $138.991B | 31.32 |
| Boston Scientific (BSX) | United States | $131.097B | 37.69 |
| EssilorLuxottica (ESLOY) | France | $109.895B | 0.00 |
| Medtronic (MDT) | Ireland | $103.904B | 15.43 |
| Haleon (HLN) | United Kingdom | $43.864B | 28.50 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.859B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.052B | 18.70 |
| ResMed (RMD) | United States | $34.830B | 28.62 |
| Terumo (TRUMY) | Japan | $28.875B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.602B | 18.07 |
| Insulet (PODD) | United States | $18.698B | 74.46 |
| Baxter (BAX) | United States | $15.062B | 9.80 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.781B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.800B | 39.43 |
| Bio-Rad Laboratories (BIO) | United States | $9.168B | 31.16 |
| Demant (WILYY) | Denmark | $7.926B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.208B | 14.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.889B | 19.34 |
| ICU Medical (ICUI) | United States | $3.840B | 36.56 |
| Haemonetics (HAE) | United States | $3.789B | 18.49 |
| Perrigo (PRGO) | Ireland | $3.513B | 10.34 |
| Envista Holdings (NVST) | United States | $3.218B | 23.97 |
| QuidelOrtho (QDEL) | United States | $3.016B | 19.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
| Neogen (NEOG) | United States | $2.609B | 30.10 |
| LeMaitre Vascular (LMAT) | United States | $2.071B | 50.34 |
| Green Thumb Industries (GTBIF) | United States | $1.678B | 29.37 |
| AtriCure (ATRC) | United States | $1.498B | 0.00 |
| InMode (INMD) | Israel | $1.434B | 8.63 |
| AdaptHealth (AHCO) | United States | $1.383B | 9.88 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.356B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.271B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.968B | 0.00 |
| Owens & Minor (OMI) | United States | $0.965B | 7.54 |
| CeriBell (CBLL) | United States | $0.964B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.879B | 15.49 |
| Evolus (EOLS) | United States | $0.690B | 0.00 |
| Omeros (OMER) | United States | $0.597B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.594B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.584B | 25.75 |
| Surmodics (SRDX) | United States | $0.568B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.452B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.439B | 0.00 |
| Quanterix (QTRX) | United States | $0.403B | 0.00 |
| ZimVie (ZIMV) | United States | $0.375B | 31.63 |
| Biote (BTMD) | United States | $0.331B | 7.26 |
| Valneva SE (VALN) | France | $0.324B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.311B | 29.56 |
| Canopy Growth (CGC) | Canada | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Cerus (CERS) | United States | $0.293B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.20 |
| Zynex (ZYXI) | United States | $0.263B | 55.00 |
| High Tide (HITI) | Canada | $0.242B | 100.33 |
| Aurora Cannabis (ACB) | Canada | $0.234B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.207B | 14.29 |
| Sanuwave Health (SNWV) | United States | $0.201B | 2.82 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.190B | 0.00 |
| Brainsway (BWAY) | Israel | $0.174B | 92.40 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.17 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.81 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| Exagen (XGN) | United States | $0.091B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.067B | 34.67 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.056B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.051B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.74 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |